Correlation between low T3 syndrome and hypertrophic cardiomyopathy

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200062574

Enrollment

Unknown

Registered

2022-08-12

Start date

2022-08-10

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic cardiomyopathy

Interventions

Low T3 syndrome group:None

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: The diagnostic criteria for hypertrophic cardiomyopathy are: 1. The diagnosis of HCM should be consistent with the following criteria: left ventricular wall or (and) septal thickness >= 15mm on echocardiography, excluding other causes of cardiac hypertrophy, such as hypertension, rheumatic heart disease mitral valve disease, congenital heart disease (atrial septal defect, ventricular septal defect) and metabolic diseases with cardiac hypertrophy. Cardiac MRI was performed if necessary; 2. Informed consent of the patient; 3. No communication barriers, able to complete the Hamilton anxiety Scale questionnaire.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. The patient has other serious diseases (advanced malignant tumor, respiratory failure, liver and kidney failure, and other diseases that seriously affect the survival of the patient); 2. Refuse to participate in the study; 3. Minors and pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
mortality;	—

Countries

China

Contacts

Public ContactHe Chaojie

Jiaxing University

hechaojie824@163.com+86 18858370824

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026